EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Candida parapsilosis : A systematic review to inform the World Health Organization fungal priority pathogens list

Mrudhula Asogan, Hannah Yejin Kim, Sarah Kidd iD, Ana Alastruey-Izquierdo iD, Nelesh P Govender iD, Aiken Dao iD, Jong-Hee Shin, Jutta Heim, Nathan Paul Ford, Valeria Gigante, Hatim Sati, C Orla Morrissey und 2 weitere

Medical Mycology · 27.06.2024 · 62 (6)

DOI: 10.1093/mmy/myad131 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Mycology, online erschienen am 27.06.2024. Verfasst von Mrudhula Asogan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Prince of Wales Hospital, South-Eastern Sydney LHD, Sydney, Australia. Hauptthemen laut MEDLINE: Candida parapsilosis, Drug Resistance, Fungal, World Health Organization, Antifungal Agents. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida parapsilosis is globally distributed and recognised for causing an increasing proportion of invasive Candida infections. It is associated with high crude mortality in all age groups. It has been particularly associated with nosocomial outbreaks, particularly in association with the use of invasive medical devices such as central venous catheters. Candida parapsilosis is one of the pathogens considered in the WHO priority pathogens list, and this review was conducted to inform the ranking of the pathogen in the list. In this systematic review, we searched PubMed and Web of Science to find studies between 2011 and 2021 reporting on the following criteria for C. parapsilosis infections: mortality, morbidity (hospitalisation and disability), drug resistance, preventability, yearly incidence, and distribution/emergence. We identified 336 potentially relevant papers, of which 51 were included in the analyses. The included studies confirmed high mortality rates, ranging from 17.5% to 46.8%. Data on disability and sequelae were sparse. Many reports highlighted concerns with azole resistance, with resistance rates of >10% described in some regions. Annual incidence rates were relatively poorly described, although there was clear evidence that the proportion of candidaemia cases caused by C. parapsilosis increased over time. While this review summarises current data on C.parapsilosis, there remains an urgent need for ongoing research and surveillance to fully understand and manage this increasingly important pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida parapsilosisDrug Resistance, FungalWorld Health OrganizationAntifungal AgentsHumansIncidenceCandidiasisCross Infection

Stichwörter der Autor:innen

Candida parapsilosisfungal infectionimmunosuppressioninvasive candidiasisnon-albicans Candida

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Prince of Wales Hospital, South-Eastern Sydney LHD, Sydney, Australia.
  • Sydney Institute of Infectious Diseases, University of Sydney, Sydney, New South Wales, Australia.
  • Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Department of Pharmacy, Westmead Hospital, Westmead, New South Wales, Australia.
  • National Mycology Reference Centre, SA Pathology, Adelaide, South Australia, Australia.
  • Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

ORCID-Profile: Sarah Kidd, Ana Alastruey-Izquierdo, Nelesh P Govender, Aiken Dao, Jan-Willem Alffenaar, Justin Beardsley

Förderung

  • World Health Organization

Zitieren

APA

Asogan, M., Kim, H. Y., Kidd, S., Alastruey-Izquierdo, A., Govender, N. P., Dao, A., Shin, J. H., Heim, J., Ford, N. P., Gigante, V., Sati, H., Morrissey, C. O., Alffenaar, J. W., & Beardsley, J. (2024). Candida parapsilosis : A systematic review to inform the World Health Organization fungal priority pathogens list. Medical Mycology, 62(6). https://doi.org/10.1093/mmy/myad131

Vancouver

Asogan M, Kim HY, Kidd S, Alastruey-Izquierdo A, Govender NP, Dao A, et al. Candida parapsilosis : A systematic review to inform the World Health Organization fungal priority pathogens list. Medical Mycology. 2024;62(6). doi:10.1093/mmy/myad131

BibTeX
@article{Asogan2024,
  author = {Asogan, Mrudhula and Kim, Hannah Yejin and Kidd, Sarah and Alastruey-Izquierdo, Ana and Govender, Nelesh P and Dao, Aiken and Shin, Jong-Hee and Heim, Jutta and Ford, Nathan Paul and Gigante, Valeria and Sati, Hatim and Morrissey, C Orla and Alffenaar, Jan-Willem and Beardsley, Justin},
  title = {Candida parapsilosis : A systematic review to inform the World Health Organization fungal priority pathogens list},
  journal = {Medical Mycology},
  year = {2024},
  volume = {62},
  number = {6},
  doi = {10.1093/mmy/myad131}
}
Kostenlos starten →